Optimizing Radiotherapy for High Risk Prostate Cancer

This is a member only event. 

This CME talk is sponsored by the Medical Society of Delaware in joint sponsorship with the Delaware Society for Oncology.

Michael J. Zelefsky, MD, Vice Chair for Clinical Research, Department of Radiation Oncology, Chief, Brachytherapy Service, Memorial Sloan Kettering Cancer Center, NYC will present “Optimizing Radiotherapy for High Risk Prostate Cancer.”

Objectives:

At the conclusion of this activity, participants will be able to:

Discuss the role of dose escalation in improving outcomes for high risk disease

Identify the role of ADT and optimal duration in conjunction with radiotherapy for high risk disease

Discuss the role of novel anti-androgens and targeted agents in the management of high risk disease